The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells
<p>Abstract</p> <p>Bortezomib is a novel anti-cancer agent which has shown promising activity in non-small lung cancer (NSCLC) patients. However, only a subset of patients respond to this treatment. We show that NSCLC cell lines are differentially sensitive to bortezomib, IC<sub...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-11-01
|
| Series: | Molecular Cancer |
| Online Access: | http://www.molecular-cancer.com/content/6/1/73 |